300 related articles for article (PubMed ID: 30569081)
1. Polygenic Risk Score Analysis of Alzheimer's Disease in Cases without APOE4 or APOE2 Alleles.
Escott-Price V; Myers A; Huentelman M; Shoai M; Hardy J
J Prev Alzheimers Dis; 2019; 6(1):16-19. PubMed ID: 30569081
[TBL] [Abstract][Full Text] [Related]
2. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
3. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
4. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
5. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.
Reiman EM; Arboleda-Velasquez JF; Quiroz YT; Huentelman MJ; Beach TG; Caselli RJ; Chen Y; Su Y; Myers AJ; Hardy J; Paul Vonsattel J; Younkin SG; Bennett DA; De Jager PL; Larson EB; Crane PK; Keene CD; Kamboh MI; Kofler JK; Duque L; Gilbert JR; Gwirtsman HE; Buxbaum JD; Dickson DW; Frosch MP; Ghetti BF; Lunetta KL; Wang LS; Hyman BT; Kukull WA; Foroud T; Haines JL; Mayeux RP; Pericak-Vance MA; Schneider JA; Trojanowski JQ; Farrer LA; Schellenberg GD; Beecham GW; Montine TJ; Jun GR;
Nat Commun; 2020 Feb; 11(1):667. PubMed ID: 32015339
[TBL] [Abstract][Full Text] [Related]
6. Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes.
Chung WS; Verghese PB; Chakraborty C; Joung J; Hyman BT; Ulrich JD; Holtzman DM; Barres BA
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10186-91. PubMed ID: 27559087
[TBL] [Abstract][Full Text] [Related]
7. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
8. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes.
de Leeuw SM; Kirschner AWT; Lindner K; Rust R; Budny V; Wolski WE; Gavin AC; Nitsch RM; Tackenberg C
Stem Cell Reports; 2022 Jan; 17(1):110-126. PubMed ID: 34919811
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E gene in physiological and pathological aging.
Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
[TBL] [Abstract][Full Text] [Related]
10. Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.
East BS; Fleming G; Peng K; Olofsson JK; Levy E; Mathews PM; Wilson DA
Neuroscience; 2018 Jun; 380():103-110. PubMed ID: 29678753
[TBL] [Abstract][Full Text] [Related]
11. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
12. Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.
Stocker H; Perna L; Weigl K; Möllers T; Schöttker B; Thomsen H; Holleczek B; Rujescu D; Brenner H
Mol Psychiatry; 2021 Oct; 26(10):5812-5822. PubMed ID: 32404947
[TBL] [Abstract][Full Text] [Related]
13. Common polygenic variation enhances risk prediction for Alzheimer's disease.
Escott-Price V; Sims R; Bannister C; Harold D; Vronskaya M; Majounie E; Badarinarayan N; ; ; Morgan K; Passmore P; Holmes C; Powell J; Brayne C; Gill M; Mead S; Goate A; Cruchaga C; Lambert JC; van Duijn C; Maier W; Ramirez A; Holmans P; Jones L; Hardy J; Seshadri S; Schellenberg GD; Amouyel P; Williams J
Brain; 2015 Dec; 138(Pt 12):3673-84. PubMed ID: 26490334
[TBL] [Abstract][Full Text] [Related]
14. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
[TBL] [Abstract][Full Text] [Related]
15. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
17. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
18. Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-ε4 carriers.
Fulton-Howard B; Goate AM; Adelson RP; Koppel J; Gordon ML; ; Barzilai N; Atzmon G; Davies P; Freudenberg-Hua Y
Neurobiol Aging; 2021 Mar; 99():101.e1-101.e9. PubMed ID: 33164815
[TBL] [Abstract][Full Text] [Related]
19. Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.
Su WH; Shi ZH; Liu SL; Wang XD; Liu S; Ji Y
Oncotarget; 2017 Jul; 8(27):43721-43732. PubMed ID: 28487499
[TBL] [Abstract][Full Text] [Related]
20. Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease.
Yokoyama JS; Bonham LW; Sears RL; Klein E; Karydas A; Kramer JH; Miller BL; Coppola G
BMC Neurol; 2015 Mar; 15():47. PubMed ID: 25880661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
